Letter to the Editor
Nkx2-4 Mutation Confers Resistance to EGFR–Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Sarcomatoid Carcinoma

https://doi.org/10.1016/j.jtho.2019.01.027Get rights and content
Under an Elsevier user license
open archive

Cited by (0)